Ketorolac-PISA-30MG/ML INJ-3AMP W/1MLIM-IV

Available

Category

Pharmaceuticals Supplies

Code

Ketorolac-PISA-30MG/ML INJ-3AMP

$6.20

Description

Provide rapid, high-potency relief from acute, debilitating pain with Ketorolaco 30mg/mL Injectable Solution. Manufactured by Laboratorios PiSA, this prescription-grade medication belongs to the Non-Steroidal Anti-inflammatory Drug (NSAID) class. It acts as a powerful non-narcotic analgesic, blocking the body's production of prostaglandins to halt intense pain signals. Designed for short-term management, this formulation is engineered for either Intramuscular (IM) or Intravenous (IV) administration by trained healthcare professionals, frequently serving as an initial therapy in post-surgical recovery or emergency clinical care.

Key Features

  • Advanced Analgesic Intensity: Specifically formulated to manage moderate-to-severe acute pain, delivering an analgesic effect comparable to low-dose opioids without the associated risk of respiratory depression or narcotic dependency.

  • Dual IM/IV Administration: Offers clinical flexibility, allowing for rapid-acting Intravenous (IV) infusion for immediate relief or Intramuscular (IM) injection for sustained absorption.

  • Effective Anti-Inflammatory Properties: In addition to its primary pain-relieving capabilities, it targets underlying tissue inflammation and swelling to accelerate early physical comfort.

  • Opioid-Sparing Effect: Frequently utilized in multimodal hospital recovery protocols to reduce the total requirement for narcotic pain medications, minimizing opioid-related side effects like severe nausea and sedation.

Common Indications for Use

Ketorolaco injectable is indicated strictly for the short-term (up to 5 days) management of acute, severe pain, including:

  • Post-Operative Recovery: Managing immediate pain following major abdominal, orthopedic, gynecological, or oral surgeries.

  • Acute Renal Colic: Relieving intense pain caused by kidney stones.

  • Severe Trauma Pain: Initial stabilization of severe pain resulting from acute musculoskeletal injuries or fractures in emergency settings.

Technical Specifications

Feature Specification
Brand / Manufacturer PiSA Agropecuaria / Laboratorios PiSA, S.A. de C.V.
Active Ingredient Ketorolaco Trometamina 30 mg
Concentration 30 mg / 1 mL
Format Injectable Solution (Solución Inyectable)
Quantity 3 Ampoules (Ampolletas) containing 1 mL each
Route of Administration Intramuscular (IM) or Intravenous (IV)
Classification Non-Narcotic NSAID Analgesic

Administration & Clinical Best Practices

Rx Only: This medication must only be prepared and administered by qualified medical staff or under direct clinical supervision.

  • Short-Term Limitation: Therapy must not exceed a maximum duration of 5 days for systemic use (combined injectable and oral treatment) to avoid severe gastrointestinal or renal complications.

  • Hydration Status: Ensure the patient is adequately hydrated prior to administration to protect renal function.

  • Transition to Oral Therapy: Injectable treatment should be swapped for an oral analgesic alternative as soon as the patient can tolerate oral medications or when the acute pain intensity subsides.

Important Safety Warnings & Precautions

  • Gastrointestinal Risk: Like all high-potency NSAIDs, Ketorolaco carries a boxed warning for gastrointestinal bleeding, ulceration, and perforation. Use with extreme caution in elderly patients.

  • Contraindications: Do not use if the patient has a history of peptic ulcer disease, active gastrointestinal bleeding, advanced renal impairment, severe dehydration, or a suspected/confirmed cerebrovascular bleed. It is strictly contraindicated for peri-operative pain management in coronary artery bypass graft (CABG) surgery.

  • Labor & Delivery: Contraindicated during labor and delivery, as it can adversely affect fetal circulation and inhibit uterine contractions.

  • Bleeding Risk: Inhibits platelet function. Do not administer to patients with severe coagulation disorders or those undergoing concurrent high-dose anticoagulant therapy.

Storage: Store in its original carton box to protect the solution from direct light. Maintain at room temperature not exceeding 30°C (86°F). Do not freeze. Keep entirely out of reach of children.